Using proteomics to identify targets of antiendothelial cell antibodies

Research output: Contribution to journalReview article


Antiendothelial cell antibodies represent a heterogeneous group of antibodies directed against a variety of antigen determinants of endothelial cells. Antibodies reacting with endothelial structures have been detected in sera from patients with autoimmune vasculitis, both primary and secondary to systemic connective tissue diseases. It may interfere with several functions and, therefore, may be a pathophysiological relevance. The analysis of the antigens recognized by antiendothelial cell antibodies showed that the antibodies are directed against a heterogeneous family of both constitutive and nonconstitutive surface endothelial proteins. Proteomics is a field of science that evaluates a large number of proteins expressed from a given cell line or organism. The technology of proteomics has been used as a method for discovering the target protein specific to a particular disease by searching for the expression or modification of the protein. Recently, progress has been made in defining the target antigens of these antibodies and proteomic technologies is one of them. This review will focus on the proteomic technologies in searching autoantigens/ autoantibodies associated with disease of the endothelium.

Original languageEnglish
Pages (from-to)983-991
Number of pages9
JournalExpert Review of Clinical Immunology
Issue number6
Publication statusPublished - 2007 Nov

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Using proteomics to identify targets of antiendothelial cell antibodies'. Together they form a unique fingerprint.

  • Cite this